Description
Exisulind induces apoptosis through the activation of protein kinase G (PKG). Exisulind exhibits antineoplastic activity in solid uMour and haematological cancer cell lines and is an inhibitor of uMour growth in rodent models of colon, prostate, bladder, mammary and lung cancer